BillionToOne BLLN
NASDAQ BLLN
$95.29 -0.93 (-0.97%)
As of: Aug 27, 2026 · 3:59 PM EDT

BillionToOne (BLLN) Non-Current Deffered Revenue (2025)

BillionToOne (BLLN) posted Non-Current Deffered Revenue of $1.3 million for Q4 2025.

BillionToOne (BLLN) Non-Current Deffered Revenue (2025) Analysis & Trends

BillionToOne has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $1.3 million in Q4 2025.

  • Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue was little changed at $1.3 million in Q4 2025 per BLLN's latest filing.
  • Over five years, Non-Current Deffered Revenue peaked at $1.3 million in Q4 2025 and troughed at $1.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 16.07 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 32.59 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 BillionToOne 4.42 Bn 3.87 Bn 77.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Mn